Published in Cytokine on March 27, 2006
Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol (2011) 2.02
Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production. J Biol Chem (2012) 1.75
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol (2007) 1.61
Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm (2009) 1.26
N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. J Nutr (2008) 1.15
Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci (2010) 1.11
The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease? Semin Immunopathol (2009) 0.96
sTRAIL levels and TRAIL gene polymorphisms in Chinese patients with fatty liver disease. Immunogenetics (2009) 0.91
Tumor Necrosis Factor-α as a Predictor for the Development of Nonalcoholic Fatty Liver Disease: A 4-Year Follow-Up Study. Endocrinol Metab (Seoul) (2013) 0.85
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling. Nat Commun (2016) 0.81
Altered phenotype and functionality of circulating immune cells characterize adult patients with nonalcoholic steatohepatitis. J Clin Immunol (2011) 0.80
Role of the sympathetic nervous system in carbon tetrachloride-induced hepatotoxicity and systemic inflammation. PLoS One (2015) 0.80
Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats. World J Gastroenterol (2008) 0.79
Increased interleukin 1 and tumor necrosis factor alpha levels after thyroid surgery. Ulus Cerrahi Derg (2014) 0.75
The relationship of Mirizzi syndrome and cholecystoenteric fistula: validation of a modified classification. World J Surg (2008) 3.09
Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci (Lond) (2004) 2.45
Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) (2004) 2.38
Conservative management of anastomotic leaks after 557 open gastric bypasses. Obes Surg (2005) 2.36
Gastric stenosis after laparoscopic sleeve gastrectomy in morbidly obese patients. Obes Surg (2013) 2.07
Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg (2009) 2.06
[Hiatal hernias: why and how should they be surgically treated]. Cir Esp (2013) 2.02
Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity. Obes Surg (2007) 1.55
Gastric leak after laparoscopic-sleeve gastrectomy for obesity. Obes Surg (2009) 1.46
A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery (2002) 1.45
Length of the esophagus in patients with gastroesophageal reflux disease and Barrett's esophagus compared to controls. Surgery (2003) 1.45
Late results of the surgical treatment of 125 patients with short-segment Barrett esophagus. Arch Surg (2009) 1.44
Could the [14C]urea breath test be proposed as a 'gold standard' for detection of Helicobacter pylori infection ? Med Sci Monit (2003) 1.44
Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic Biol Med (2004) 1.38
Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery. Obes Surg (2008) 1.34
Thalidomide for the treatment of metastatic hepatic epithelioid hemangioendothelioma: a case report with a long term follow-up. Ann Hepatol (2011) 1.26
High-flow nasal cannula: impact on oxygenation and ventilation in an acute lung injury model. Pediatr Pulmonol (2010) 1.23
Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months. Ann Surg (2006) 1.21
Changes in resting energy expenditure and body composition after weight loss following Roux-en-Y gastric bypass. Obes Surg (2007) 1.21
Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochim Biophys Acta (2009) 1.20
CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD. Respir Med (2013) 1.18
Up-regulation of PPAR-gamma mRNA expression in the liver of obese patients: an additional reinforcing lipogenic mechanism to SREBP-1c induction. J Clin Endocrinol Metab (2011) 1.15
Zinc absorption and zinc status are reduced after Roux-en-Y gastric bypass: a randomized study using 2 supplements. Am J Clin Nutr (2011) 1.14
Mirizzi syndrome and gallstone ileus: an unusual presentation of gallstone disease. J Gastrointest Surg (2005) 1.13
Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease. Trends Mol Med (2006) 1.11
Alcohol absorption modification after a laparoscopic sleeve gastrectomy due to obesity. Obes Surg (2010) 1.09
Thyroid hormone preconditioning: protection against ischemia-reperfusion liver injury in the rat. Hepatology (2007) 1.08
Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol (2005) 1.04
Latest results (12-21 years) of a prospective randomized study comparing Billroth II and Roux-en-Y anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers. Ann Surg (2009) 1.04
Is laparoscopic sleeve gastrectomy an acceptable primary bariatric procedure in obese patients? Early and 5-year postoperative results. Surg Laparosc Endosc Percutan Tech (2012) 1.02
Gastric leak after sleeve gastrectomy: analysis of its management. Obes Surg (2011) 1.02
Liver NF-kappaB and AP-1 DNA binding in obese patients. Obesity (Silver Spring) (2009) 1.01
Decreased liver fatty acid delta-6 and delta-5 desaturase activity in obese patients. Obesity (Silver Spring) (2009) 0.99
Incidence of anastomotic strictures after gastric bypass: a prospective consecutive routine endoscopic study 1 month and 17 months after surgery in 441 patients with morbid obesity. Obes Surg (2008) 0.98
Effects of prone positioning on lung protection in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (2013) 0.98
Thyroid hormone-induced oxidative stress triggers nuclear factor-kappaB activation and cytokine gene expression in rat liver. Free Radic Biol Med (2003) 0.97
N-3 PUFA supplementation triggers PPAR-α activation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemia-reperfusion injury. PLoS One (2011) 0.96
Antioxidant therapy reduces oxidative and inflammatory tissue damage in patients subjected to cardiac surgery with extracorporeal circulation. Basic Clin Pharmacol Toxicol (2010) 0.96
A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy. Obes Surg (2008) 0.95
Iron absorption and iron status are reduced after Roux-en-Y gastric bypass. Am J Clin Nutr (2009) 0.94
Polyunsaturated fatty acid pattern in liver and erythrocyte phospholipids from obese patients. Obesity (Silver Spring) (2007) 0.93
Oxidative stress as a novel target in pediatric sepsis management. J Crit Care (2010) 0.92
Evaluation of the radiological gastric capacity and evolution of the BMI 2-3 years after sleeve gastrectomy. Obes Surg (2009) 0.92
Thyroid hormone-induced oxidative stress in rodents and humans: a comparative view and relation to redox regulation of gene expression. Comp Biochem Physiol C Toxicol Pharmacol (2005) 0.92
Evolution of type 2 diabetes mellitus in non morbid obese gastrectomized patients with Roux en-Y reconstruction: retrospective study. World J Surg (2010) 0.91
Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver. Nutrition (2005) 0.91
Protection against in vivo liver ischemia-reperfusion injury by n-3 long-chain polyunsaturated fatty acids in the rat. Free Radic Res (2010) 0.91
Paricalcitol for reduction of albuminuria in diabetes. Lancet (2011) 0.91
Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett's esophagus: a prospective study. Obes Surg (2012) 0.91
[A proposal of guidelines for surgical management of obesity]. Rev Med Chil (2005) 0.90
Implications of oxidative stress in the pathophysiology of obstructive uropathy. Urol Res (2008) 0.89
Effect of gastric bypass on Barrett's esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg (2006) 0.88
Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia. Am J Gastroenterol (2002) 0.88
Laparoscopic sleeve gastrectomy: surgical technique, indications and clinical results. Obes Surg (2007) 0.88
Study of cytochrome P450 2E1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women. Biol Res (2008) 0.88
Gastroesophageal reflux disease after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech (2010) 0.87
Chemoradiotherapy in gallbladder cancer. J Surg Oncol (2006) 0.87
The importance of the long-chain polyunsaturated fatty acid n-6/n-3 ratio in development of non-alcoholic fatty liver associated with obesity. Food Funct (2011) 0.87
Type 2 diabetes mellitus in patients with mild obesity: preliminary results of surgical treatment. Obes Surg (2013) 0.87
Neosaxitoxin as a local anesthetic: preliminary observations from a first human trial. Anesthesiology (2007) 0.87
Relationship between in vivo chlorzoxazone hydroxylation, hepatic cytochrome P450 2E1 content and liver injury in obese non-alcoholic fatty liver disease patients. Hepatol Res (2006) 0.86